DrugDashboards

Rocuronium Bromide

Rocuronium Bromide · ROCURONIUM BROMIDE 10 mg/mL · Injection · Intravenous · Hikma Pharmaceuticals USA Inc.

NDC 00143-9251-10 · 10 VIAL in 1 BOX / 10 mL in 1 VIAL · ANDA · View full market →

The short version

13 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$60.00
Reported to Texas DSHS · 2026 annual filing · Hikma Pharmaceuticals USA Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$1,371
213 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.4%chance of a new FDA shortage posting for rocuronium bromide (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA204679
TE code
AP
Approval date
Feb 28, 2017
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Rocuronium Bromide (Injection)

LabelerStrengthFirst seenLast seen
Civica, Inc.ROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Gland Pharma LimitedROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
HF Acquisition Co. LLC, DBA HealthFirstROCURONIUM BROMIDE 10 mg/mLAug 14, 2026Sep 3, 2026
Meitheal Pharmaceuticals Inc.ROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
B. Braun Medical Inc.ROCURONIUM BROMIDE 50 mg/5mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationROCURONIUM BROMIDE 50 mg/5mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationROCURONIUM BROMIDE 100 mg/10mLJul 15, 2026Sep 2, 2026
Lifestar Pharma LLCROCURONIUM BROMIDE 50 mg/5mLJul 15, 2026Sep 2, 2026
Lifestar Pharma LLCROCURONIUM BROMIDE 100 mg/10mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCROCURONIUM BROMIDE 50 mg/5mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionROCURONIUM BROMIDE 10 mg/mLJul 29, 2026Sep 2, 2026
Sagent PharmaceuticalsROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Solco Healthcare US, LLCROCURONIUM BROMIDE 50 mg/5mLJul 15, 2026Sep 2, 2026
Solco Healthcare US, LLCROCURONIUM BROMIDE 100 mg/10mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.ROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Rocuronium Bromide — NDC 00143-9251-10," retrieved September 3, 2026, https://drugdashboards.com/drug/00143925110.

Free to cite with attribution — see how the data is put together.